Arcutis Biotherapeutics, Inc. (ARQT)
21.61
+0.50
(+2.37%)
USD |
NASDAQ |
May 27, 15:00
Arcutis Biotherapeutics Free Cash Flow : 16.92M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| ADMA Biologics, Inc. | 107.55M |
| MannKind Corp. | 13.07M |
| PTC Therapeutics, Inc. | -516.78M |
| Ultragenyx Pharmaceutical, Inc. | -507.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.239M |
| Cash from Investing (Quarterly) | -11.33M |
| Cash from Financing (Quarterly) | 1.067M |
| Free Cash Flow Per Share (Quarterly) | 0.0173 |
| Free Cash Flow to Equity (Quarterly) | 1.793M |
| Free Cash Flow to Firm (Quarterly) | 6.643M |
| Free Cash Flow Yield | 0.60% |